Diagnostics & Research industry stocks
The Diagnostics & Research industry has 52 US-listed companies on stockrow and is part of the Healthcare sector, with a combined market value of $915.8B. Thermo Fisher Scientific Inc. (TMO) is the largest at $251.4B, followed by Danaher Corporation and Natera, Inc.. The median Diagnostics & Research stock trades at 33.9× trailing earnings, above the market median of 17.9×, with a median net margin of −6.37% (market: 0.55%). Median revenue growth over the last twelve months is 7.69%. 7 of the 52 pay a dividend; the median yield among payers is 0.70%.
Diagnostics & Research medians
| Metric | Industry | Market |
|---|---|---|
| P/E | 33.9× | 17.9× |
| P/S | 4.9× | 2.0× |
| P/B | 3.1× | 1.8× |
| Price to free cash flow | 34.0× | 14.0× |
| EV/EBITDA | 25.2× | 11.0× |
| EV/Sales | 5.7× | 2.2× |
| Earnings yield | −1.75% | 1.18% |
| Free cash flow yield | −0.13% | 0.48% |
| Gross margin | 50.9% | 46.3% |
| Operating margin | −8.57% | 0.00% |
| Net margin | −6.37% | 0.55% |
| Free cash flow margin | 0.00% | 0.00% |
| Return on equity | −2.92% | 1.76% |
| Return on assets | −6.71% | 0.00% |
| Return on invested capital | 0.00% | 0.00% |
| Revenue growth (TTM) | 7.69% | 7.41% |
| Revenue growth, 5-year CAGR | 7.40% | 8.85% |
| Net income growth, 5-year CAGR | 0.00% | 0.00% |
| Debt to equity | 0.1× | 0.2× |
| Current ratio | 2.0× | 1.6× |
| Net debt to EBITDA | 0.8× | 0.6× |
| Dividend yield | 0.70% | 2.75% |
| Payout ratio | 0.0× | 0.0× |
| Market cap | $2.6B | $612.7M |
Today’s biggest moves
All 52 companies
Open in screener| TMO | Thermo Fisher Scientific Inc. | 251.43b | 675.00 | (0.50%) | 36.25 | 15.04% | 7.23% | 0.27% |
|---|---|---|---|---|---|---|---|---|
| DHR | Danaher Corporation | 155.91b | 224.49 | 0.34% | 39.74 | 15.95% | 4.56% | 0.39% |
| NTRA | Natera, Inc. | 59.17b | 412.56 | 0.92% | 0.00 | (7.11%) | 37.82% | — |
| A | Agilent Technologies, Inc. | 49.02b | 172.79 | (0.03%) | 33.95 | 19.53% | 8.60% | 0.70% |
| IQV | IQVIA Holdings Inc. | 45.27b | 270.37 | (1.69%) | 33.26 | 8.10% | 8.17% | — |
| WAT | Waters Corporation | 42.28b | 433.54 | 0.86% | 107.97 | 3.59% | 52.47% | — |
| ILMN | Illumina, Inc. | 41.25b | 270.00 | (0.48%) | 50.39 | 18.36% | 4.88% | — |
| IDXX | IDEXX Laboratories, Inc. | 40.18b | 519.26 | 1.14% | 36.24 | 25.03% | 12.77% | — |
| MTD | Mettler-Toledo International, Inc. | 30.44b | 1,511.64 | (0.49%) | 33.94 | 21.91% | 6.91% | — |
| DGX | Quest Diagnostics Incorporated | 26.19b | 236.32 | (0.11%) | 24.77 | 9.15% | 9.87% | 2.30% |
| GH | Guardant Health, Inc. | 23.94b | 177.25 | 0.45% | 0.00 | (38.33%) | 42.74% | — |
| LH | Labcorp Holdings Inc. | 21.86b | 309.64 | 0.22% | 25.44 | 6.99% | 6.41% | 0.98% |
| MEDP | Medpace Holdings, Inc. | 17.32b | 618.88 | (0.28%) | 35.59 | 17.67% | 24.67% | — |
| RVTY | Revvity Inc. | 16.81b | 151.11 | 0.29% | 71.96 | 8.16% | 4.05% | 0.27% |
| CRL | Charles River Laboratories International, Inc. | 14.09b | 292.84 | (0.54%) | 0.00 | (5.96%) | (0.74%) | — |
| ICLR | ICON PLC | 13.42b | 172.33 | (0.90%) | 257.44 | 0.51% | 3.26% | — |
| TWST | Twist Bioscience Corporation | 12.39b | 182.83 | (0.39%) | 0.00 | (31.66%) | 19.19% | — |
| QGEN | QIAGEN N.V. | 9.26b | 44.18 | (0.85%) | 22.64 | 19.49% | 2.96% | — |
| BLLN | BillionToOne, Inc. | 5.89b | 123.08 | (1.46%) | 119.22 | 8.35% | — | — |
| RDNT | RadNet, Inc. | 5.60b | 70.79 | (0.73%) | 0.00 | (0.93%) | 18.92% | — |
| GRAL | GRAIL, Inc. | 5.54b | 126.89 | 1.34% | 0.00 | (236.95%) | 23.07% | — |
| SHC | Sotera Health Company | 5.27b | 18.34 | (0.70%) | 32.14 | 13.44% | 8.15% | — |
| ADPT | Adaptive Biotechnologies Corporation | 4.71b | 29.43 | (0.47%) | 0.00 | (20.73%) | 50.13% | — |
| VCYT | Veracyte, Inc. | 3.91b | 45.43 | (6.41%) | 31.55 | 20.37% | 17.28% | — |
| CDNA | CareDx, Inc. | 3.18b | 63.68 | 3.76% | 29.62 | 24.23% | 34.41% | — |
| WGS | GeneDx Holdings Corp. | 2.61b | 88.40 | (0.09%) | 0.00 | (23.40%) | 25.42% | — |
| NEO | NeoGenomics, Inc. | 2.50b | 19.33 | (1.18%) | 0.00 | (6.77%) | 11.19% | — |
| PSNL | Personalis, Inc. | 1.77b | 16.46 | (0.66%) | 0.00 | (153.84%) | (13.26%) | — |
| OPK | OPKO Health, Inc. | 1.22b | 1.64 | 0.00% | 0.00 | (12.40%) | (11.47%) | — |
| CSTL | Castle Biosciences, Inc. | 1.08b | 35.81 | 1.17% | 0.00 | (5.43%) | 3.18% | — |
| FLGT | Fulgent Genetics, Inc. | 592.95m | 22.20 | 3.02% | 0.00 | (26.05%) | 6.83% | — |
| MYGN | Myriad Genetics, Inc. | 395.99m | 4.17 | 0.72% | 0.00 | (13.96%) | (3.16%) | — |
| BDSX | Biodesix, Inc. | 310.20m | 29.10 | (1.02%) | 0.00 | (26.97%) | 34.46% | — |
| XGN | Exagen Inc. | 233.29m | 8.72 | (0.23%) | 0.00 | (26.61%) | 20.83% | — |
| BNR | Burning Rock Biotech Limited Sponsored ADR | 158.22m | 18.60 | 3.33% | 0.00 | (13.51%) | (0.14%) | — |
| IMDX | Insight Molecular Diagnostics Inc. | 129.26m | 3.92 | (0.76%) | 0.00 | (2,955.63%) | (60.77%) | — |
| QUCY | Quantum Cyber N.V | 113.36m | 1.37 | 4.55% | 0.00 | 0.00% | 68.99% | — |
| MDXHF | MedX Health Corp. | 103.16m | 0.03 | 0.00% | 0.00 | (1,094.99%) | 9.96% | — |
| MBAI | MBody AI Ltd. | 68.97m | 4.59 | 1.77% | 0.00 | 0.00% | — | — |
| MDXH | MDxHealth SA | 55.53m | 0.57 | (1.72%) | 0.00 | (32.53%) | 21.46% | — |
| PRPO | Precipio, Inc. | 43.81m | 23.65 | (3.35%) | 0.00 | (4.47%) | 28.04% | — |
| PMD | Psychemedics Corporation | 15.70m | 2.67 | 0.00% | 0.00 | (9.45%) | (10.92%) | 4.79% |
| ADVB | Advanced Biomed Inc. | 10.42m | 6.38 | 3.01% | 1.35 | 0.00% | — | — |
| BIAF | bioAffinity Technologies, Inc. | 9.00m | 7.93 | 1.28% | 0.00 | (257.33%) | (23.18%) | — |
| NDRA | ENDRA Life Sciences Inc. | 8.89m | 6.04 | 1.85% | 0.00 | 0.00% | — | — |
| XWEL | XWELL, Inc. | 7.64m | 0.89 | 0.00% | 0.00 | (117.83%) | (7.58%) | — |
| TTOO | T2 Biosystems, Inc. | 6.48m | 0.00 | 0.00% | 0.00 | (559.52%) | (30.19%) | — |
| DMTKQ | DermTech, Inc. | 3.29m | 0.00 | 0.00% | 0.00 | (572.19%) | 9.71% | — |
| ISPC | iSpecimen Inc. | 3.12m | 1.26 | 0.80% | 0.00 | (2,449.02%) | (92.11%) | — |
| NOTVQ | Inotiv, Inc. | 2.79m | 0.01 | 0.00% | 0.00 | (17.14%) | 5.61% | — |
| AWHL | Aspira Women's Health Inc. | 2.44m | 0.26 | 0.00% | 0.00 | (117.07%) | (8.00%) | — |
| PRPH | ProPhase Labs, Inc. | 1.17m | 0.01 | 0.00% | 0.00 | (717.43%) | (43.52%) | — |